glp 1 study Discovery of GLP-1–Based Drugs for the Treatment of Obesity The GLP-1 trend: What the

Throughout the study timeframe, 961 participants using GLP-1RAs developed depression, and 902 participants using SGLT2is developed depression

& Lavebratt, C

Proponents of coffee enemas also claim that they improve yeast (Candida) overgrowth

Medications Semaglutide, known by the brand name Wegovy, and liraglutide (Saxenda) have been specifically approved for weight loss in obesity, in combination with lifestyle changes

(2,3) Mycotoxins have also been shown to impair glutathione recycling, disrupt NRF2-mediated antioxidant signaling, and increase oxidative stress burden, further compromising mitochondrial efficiency and redox balance